Y-Intercept (HK)’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$484K Sell
18,275
-65,180
-78% -$1.69M 0.01% 1289
2026
Q2
$2.18M Buy
+83,455
New +$2.12M 0.04% 650
2026
Q1
– Sell
-22,643
Closed -$596K – 2132
2025
Q4
$596K Buy
+22,643
New +$494K 0.01% 1179
2024
Q4
– Sell
-11,724
Closed -$147K – 1739
2024
Q3
$147K Sell
11,724
-46,586
-80% -$507K 0.01% 1197
2024
Q2
$496K Buy
58,310
+20,664
+55% +$184K 0.03% 810
2024
Q1
$396K Buy
+37,646
New +$418K 0.03% 830
2022
Q4
– Sell
-25,374
Closed -$156K – 1413
2022
Q3
$156K Buy
+25,374
New +$153K 0.02% 849

Other funds holding ZYME

Y-Intercept (HK)'s ZYME Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Zymeworks (ZYME) stake by 78% in Q3 2026, selling an estimated $1.69M and leaving 18,275 shares worth $484K. The position accounts for 0.01% of the portfolio, ranked #1289.

Y-Intercept (HK) first reported a position in ZYME in Q3 2022 and has held it in 7 quarters since. The position peaked at $2.18M in Q2 2026. 21 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Y-Intercept (HK) held 18,275 shares of Zymeworks worth $484K as of Q3 2026.
  • Y-Intercept (HK) sold 65,180 Zymeworks shares in Q3 2026, an estimated $1.69M.
  • Zymeworks made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1289 holding.
  • Y-Intercept (HK) first reported a position in Zymeworks in Q3 2022 and has held it in 7 quarters since.
  • Y-Intercept (HK)'s Zymeworks position peaked at $2.18M in Q2 2026.
  • 21 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.